10月，由于担心新型血液稀释剂希美加群（Exanta）的副作用，FDA保留了该药品的上市批准。
基于72个网页-相关网页
Halperin's study, called Sportif V, followed 3, 922 patients who were randomly given either warfarin or Exanta.
FORBES: Magazine Article
There are concerns about Exanta, mostly surrounding elevations in liver enzymes that occur with the drug.
FORBES: Replacing Coumadin
Exanta won't reach the market for at least two years, but it clearly has blockbuster potential.
FORBES: America's Riskiest Drugs: Warfarin
应用推荐
模块上移
模块下移
不移动